SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-151749
Filing Date
2017-05-01
Accepted
2017-05-01 16:02:04
Documents
52
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d382546d10q.htm 10-Q 715996
2 EX-31.1 d382546dex311.htm EX-31.1 6186
3 EX-31.2 d382546dex312.htm EX-31.2 6221
4 EX-32.1 d382546dex321.htm EX-32.1 4516
11 GRAPHIC g382546g32a64.jpg GRAPHIC 109129
  Complete submission text file 0001193125-17-151749.txt   3679175

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ziop-20170331.xml EX-101.INS 455312
6 XBRL TAXONOMY EXTENSION SCHEMA ziop-20170331.xsd EX-101.SCH 40763
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20170331_cal.xml EX-101.CAL 38607
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20170331_def.xml EX-101.DEF 188943
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20170331_lab.xml EX-101.LAB 352903
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20170331_pre.xml EX-101.PRE 262948
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 17800645
SIC: 2834 Pharmaceutical Preparations